Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2002 May;57(5):429–434. doi: 10.1136/thorax.57.5.429

Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome

K Shimizu 1, K Chin 1, T Nakamura 1, H Masuzaki 1, Y Ogawa 1, R Hosokawa 1, A Niimi 1, N Hattori 1, R Nohara 1, S Sasayama 1, K Nakao 1, M Mishima 1, T Nakamura 1, M Ohi 1
PMCID: PMC1746321  PMID: 11978920

Abstract

Background: The control of body weight and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome (OSAHS) are important because both factors have significant effects on the mortality of these patients. It has recently been reported that OSAHS has a significant effect on the secretion of leptin, a hormone involved in the control of body weight and sympathetic nerve activity. In addition to the circadian rhythm of leptin secretion, the effects of one night of treatment with nasal continuous positive airway pressure (nCPAP) and the mechanism of the effects of nCPAP on nocturnal leptin secretion in patients with OSAHS has not yet been elucidated.

Methods: Blood samples were obtained at 21.00 hours, 00.00 hours, 03.00 hours, and 06.30 hours from 21 subjects with OSAHS (mean apnoea and hypopnoea index 52.4/h), with and without nCPAP treatment. Iodine-123 (I123)-meta-iodobenzylguanidine (MIBG) imaging was used to evaluate myocardial sympathetic function before nCPAP treatment.

Results: Plasma leptin reached a peak level at 00:00 hours (p<0.01) in patients with OSAHS, both with and without nCPAP treatment. The first night of nCPAP treatment significantly decreased the plasma leptin levels at 03.00 hours (without nCPAP: mean (SE) 21.6 (4.7) ng/ml; with nCPAP: 19.3 (4.1) ng/ml, p<0.02) and at 06.30 hours (without nCPAP: 17.6 (3.8) ng/ml; with nCPAP: 15.2 (3.2) ng/ml, p<0.01). The magnitude of the decrease in leptin levels after nCPAP treatment was significantly correlated with cardiac sympathetic function measured before nCPAP treatment (p<0.03).

Conclusions: Patients with OSAHS undergo nocturnal increases in leptin levels in spite of interruption of sleep due to apnoea and hypopnoea, a trend seen in normal subjects. Plasma leptin levels in patients with OSAHS decreased significantly after the first night of nCPAP treatment. Enhanced cardiac sympathetic function in these patients may contribute to the leptin levels before nCPAP treatment and vice versa.

Full Text

The Full Text of this article is available as a PDF (181.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aizawa-Abe M., Ogawa Y., Masuzaki H., Ebihara K., Satoh N., Iwai H., Matsuoka N., Hayashi T., Hosoda K., Inoue G. Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest. 2000 May;105(9):1243–1252. doi: 10.1172/JCI8341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Auwerx J., Staels B. Leptin. Lancet. 1998 Mar 7;351(9104):737–742. doi: 10.1016/S0140-6736(97)06348-4. [DOI] [PubMed] [Google Scholar]
  3. Barzilai N., Wang J., Massilon D., Vuguin P., Hawkins M., Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest. 1997 Dec 15;100(12):3105–3110. doi: 10.1172/JCI119865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chin K., Ohi M., Kita H., Noguchi T., Otsuka N., Tsuboi T., Mishima M., Kuno K. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med. 1996 Jun;153(6 Pt 1):1972–1976. doi: 10.1164/ajrccm.153.6.8665063. [DOI] [PubMed] [Google Scholar]
  5. Chin K., Shimizu K., Nakamura T., Narai N., Masuzaki H., Ogawa Y., Mishima M., Nakamura T., Nakao K., Ohi M. Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation. 1999 Aug 17;100(7):706–712. doi: 10.1161/01.cir.100.7.706. [DOI] [PubMed] [Google Scholar]
  6. Collins S., Kuhn C. M., Petro A. E., Swick A. G., Chrunyk B. A., Surwit R. S. Role of leptin in fat regulation. Nature. 1996 Apr 25;380(6576):677–677. doi: 10.1038/380677a0. [DOI] [PubMed] [Google Scholar]
  7. Considine R. V., Sinha M. K., Heiman M. L., Kriauciunas A., Stephens T. W., Nyce M. R., Ohannesian J. P., Marco C. C., McKee L. J., Bauer T. L. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996 Feb 1;334(5):292–295. doi: 10.1056/NEJM199602013340503. [DOI] [PubMed] [Google Scholar]
  8. Haynes W. G., Morgan D. A., Walsh S. A., Mark A. L., Sivitz W. I. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997 Jul 15;100(2):270–278. doi: 10.1172/JCI119532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hosoda K., Masuzaki H., Ogawa Y., Miyawaki T., Hiraoka J., Hanaoka I., Yasuno A., Nomura T., Fujisawa Y., Yoshimasa Y. Development of radioimmunoassay for human leptin. Biochem Biophys Res Commun. 1996 Apr 16;221(2):234–239. doi: 10.1006/bbrc.1996.0579. [DOI] [PubMed] [Google Scholar]
  10. Ip M. S., Lam K. S., Ho C., Tsang K. W., Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000 Sep;118(3):580–586. doi: 10.1378/chest.118.3.580. [DOI] [PubMed] [Google Scholar]
  11. Lanza G. A., Giordano A., Pristipino C., Calcagni M. L., Meduri G., Trani C., Franceschini R., Crea F., Troncone L., Maseri A. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy. Circulation. 1997 Aug 5;96(3):821–826. doi: 10.1161/01.cir.96.3.821. [DOI] [PubMed] [Google Scholar]
  12. Li K. K., Powell N. B., Kushida C., Riley R. W., Adornato B., Guilleminault C. A comparison of Asian and white patients with obstructive sleep apnea syndrome. Laryngoscope. 1999 Dec;109(12):1937–1940. doi: 10.1097/00005537-199912000-00007. [DOI] [PubMed] [Google Scholar]
  13. Licinio J., Mantzoros C., Negrão A. B., Cizza G., Wong M. L., Bongiorno P. B., Chrousos G. P., Karp B., Allen C., Flier J. S. Human leptin levels are pulsatile and inversely related to pituitary-adrenal function. Nat Med. 1997 May;3(5):575–579. doi: 10.1038/nm0597-575. [DOI] [PubMed] [Google Scholar]
  14. Masuzaki H., Ogawa Y., Isse N., Satoh N., Okazaki T., Shigemoto M., Mori K., Tamura N., Hosoda K., Yoshimasa Y. Human obese gene expression. Adipocyte-specific expression and regional differences in the adipose tissue. Diabetes. 1995 Jul;44(7):855–858. doi: 10.2337/diab.44.7.855. [DOI] [PubMed] [Google Scholar]
  15. Masuzaki H., Ogawa Y., Sagawa N., Hosoda K., Matsumoto T., Mise H., Nishimura H., Yoshimasa Y., Tanaka I., Mori T. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med. 1997 Sep;3(9):1029–1033. doi: 10.1038/nm0997-1029. [DOI] [PubMed] [Google Scholar]
  16. Merlet P., Benvenuti C., Moyse D., Pouillart F., Dubois-Randé J. L., Duval A. M., Loisance D., Castaigne A., Syrota A. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med. 1999 Jun;40(6):917–923. [PubMed] [Google Scholar]
  17. Otsuka N., Ohi M., Chin K., Kita H., Noguchi T., Hata T., Nohara R., Hosokawa R., Fujita M., Kuno K. Assessment of cardiac sympathetic function with iodine-123-MIBG imaging in obstructive sleep apnea syndrome. J Nucl Med. 1997 Apr;38(4):567–572. [PubMed] [Google Scholar]
  18. Phillips B. G., Kato M., Narkiewicz K., Choe I., Somers V. K. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol. 2000 Jul;279(1):H234–H237. doi: 10.1152/ajpheart.2000.279.1.H234. [DOI] [PubMed] [Google Scholar]
  19. Rosenbaum M., Nicolson M., Hirsch J., Heymsfield S. B., Gallagher D., Chu F., Leibel R. L. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 1996 Sep;81(9):3424–3427. doi: 10.1210/jcem.81.9.8784109. [DOI] [PubMed] [Google Scholar]
  20. Schoeller D. A., Cella L. K., Sinha M. K., Caro J. F. Entrainment of the diurnal rhythm of plasma leptin to meal timing. J Clin Invest. 1997 Oct 1;100(7):1882–1887. doi: 10.1172/JCI119717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shimomura I., Hammer R. E., Ikemoto S., Brown M. S., Goldstein J. L. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature. 1999 Sep 2;401(6748):73–76. doi: 10.1038/43448. [DOI] [PubMed] [Google Scholar]
  22. Sinha M. K., Ohannesian J. P., Heiman M. L., Kriauciunas A., Stephens T. W., Magosin S., Marco C., Caro J. F. Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest. 1996 Mar 1;97(5):1344–1347. doi: 10.1172/JCI118551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Snitker S., Pratley R. E., Nicolson M., Tataranni P. A., Ravussin E. Relationship between muscle sympathetic nerve activity and plasma leptin concentration. Obes Res. 1997 Jul;5(4):338–340. doi: 10.1002/j.1550-8528.1997.tb00561.x. [DOI] [PubMed] [Google Scholar]
  24. Sobhani I., Bado A., Vissuzaine C., Buyse M., Kermorgant S., Laigneau J. P., Attoub S., Lehy T., Henin D., Mignon M. Leptin secretion and leptin receptor in the human stomach. Gut. 2000 Aug;47(2):178–183. doi: 10.1136/gut.47.2.178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Somers V. K., Dyken M. E., Clary M. P., Abboud F. M. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995 Oct;96(4):1897–1904. doi: 10.1172/JCI118235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Söderberg S., Ahrén B., Jansson J. H., Johnson O., Hallmans G., Asplund K., Olsson T. Leptin is associated with increased risk of myocardial infarction. J Intern Med. 1999 Oct;246(4):409–418. doi: 10.1046/j.1365-2796.1999.00571.x. [DOI] [PubMed] [Google Scholar]
  27. Söderberg S., Ahrén B., Stegmayr B., Johnson O., Wiklund P. G., Weinehall L., Hallmans G., Olsson T. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke. 1999 Feb;30(2):328–337. doi: 10.1161/01.str.30.2.328. [DOI] [PubMed] [Google Scholar]
  28. Söderberg S., Olsson T., Eliasson M., Johnson O., Ahrén B. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med. 1999 May;245(5):533–543. doi: 10.1046/j.1365-2796.1999.00472.x. [DOI] [PubMed] [Google Scholar]
  29. Vgontzas A. N., Papanicolaou D. A., Bixler E. O., Hopper K., Lotsikas A., Lin H. M., Kales A., Chrousos G. P. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000 Mar;85(3):1151–1158. doi: 10.1210/jcem.85.3.6484. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES